Do patients with nonalcoholic fatty liver disease die from their heart?

Clinics and Research in Hepatology and Gastroenterology

Volumn 35, Issue 3, 2011, Pages 163-165

  Erlinger, Serge ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052718755     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2010.12.010     Document Type: Article

References (20)

1. Angulo, P., Nonalcoholic fatty liver disease. N Engl J Med 346:16 (2002), 1221–1231.
2. Marchesini, G., Moscatiello, S., Di Domizio, S., Forlani, G., Obesity-associated liver disease. J Clin Endocrinol Metab 93:11 Suppl. 1 (2008), 74–80.
3. Targher, G., Day, C.P., Bonora, E., Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363:14 (2010), 1341–1350.
4. Sookoian, S., Pirola, C.J., Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol 49:4 (2008), 600–607.
5. Targher, G., Bertolini, L., Padovani, R., Rodella, S., Zoppini, G., Zenari, L., et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 29:6 (2006), 1325–1330.
6. Targher, G., Bertolini, L., Padovani, R., Rodella, S., Tessari, R., Zenari, L., et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30:5 (2007), 1212–1218.
7. Targher, G., Bertolini, L., Padovani, R., Rodella, S., Zoppini, G., Pichiri, I., et al. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. J Hepatol 53:4 (2010), 713–718.
8. Lin, Y.C., Lo, H.M., Chen, J.D., Sonographic fatty liver, overweight and ischemic heart disease. World J Gastroenterol 11:31 (2005), 4838–4842.
9. Schwimmer JB, Deutsch R, Behling C, Lavine JE. Fatty liver as a determinant of atherosclerosis. Hepatology. 2005;42(Suppl. 610A) (Abstract).
10. Ghouri, N., Preiss, D., Sattar, N., Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology 52:3 (2010), 1156–1161.
11. Adams, L.A., Lymp, J.F., St Sauver, J., Sanderson, S.O., Lindor, K.D., Feldstein, A., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129:1 (2005), 113–121.
12. Rafiq, N., Bai, C., Fang, Y., Srishord, M., McCullough, A., Gramlich, T., et al. Long term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 7:2 (2009), 234–238.
13. Ekstedt, M., Franzén, L.E., Mathiesen, U.L., Thorelius, L., Holmqvist, M., Bodemar, G., et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44:4 (2006), 865–873.
14. Söderberg, C., Stål, P., Askling, J., Glaumann, H., Lindberg, G., Marmur, J., et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 51:2 (2010), 595–602.
15. Day, C.P., From fat to inflammation. Gastroenterology 130:1 (2006), 207–210.
16. Shoelson, S.E., Herrero, L., Naaz, A., Obesity, inflammation, and insulin resistance. Gastroenterology 132:6 (2007), 2169–2180.
17. Stefan, N., Kantartzis, K., Häring, H.U., Causes and metabolic consequences of fatty liver. Endocr Rev 29:7 (2008), 939–960.
18. Tilg, H., Moschen, A.R., Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol Metab 19:10 (2008), 371–379.
19. Targher, G., Chonchol, M., Miele, L., Zoppini, G., Pichiri, I., Muggeo, M., Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome. Semin Thromb Hemost 35:3 (2009), 277–287.
20. Targher, G., Marra, F., Marchesini, G., Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?. Diabetologia 51:11 (2008), 1947–1953.